Impact of Precision Medicine in Oncology Immuno-oncology

被引:0
|
作者
Buchbinder, Elizabeth I. [1 ,2 ,3 ,5 ]
Hodi, F. Stephen [1 ,2 ,3 ,4 ]
机构
[1] Dana Farber Canc Inst, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
[2] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med, Boston, MA USA
[3] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[4] Dana Farber Canc Inst, Ctr Immuno Oncol, Boston, MA USA
[5] 450 Brookline Ave, Boston, MA 02215 USA
来源
CANCER JOURNAL | 2023年 / 29卷 / 01期
关键词
CAR-T cell; immune checkpoint inhibition; immunotherapy; cellular therapy; cytokine; TIL therapy; INTERLEUKIN-2 HD IL-2; RENAL-CELL CARCINOMA; METASTATIC MELANOMA; T-CELLS; PD-1; CTLA-4; THERAPY; IMMUNOTHERAPY; IPILIMUMAB; BLOCKADE;
D O I
10.1097/PPO.0000000000000641
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer treatment has dramatically changed over the last decade with the development of immunotherapy. Therapies including immune cytokines, immune checkpoint inhibition, intratumoral therapies, and cellular therapies are already widely used in the oncology clinic. Active development continues in these areas and in the development of vaccines, bispecific therapies, and more refined cellular therapies. In this review, we will examine the role that immune therapy has in cancer treatment and explore areas of future development.
引用
收藏
页码:15 / 19
页数:5
相关论文
共 50 条
  • [1] Immuno-oncology and precision medicine: The clinician point of view
    Borg, Christophe
    ANNALES DE PATHOLOGIE, 2017, 37 (01) : 5 - 6
  • [2] Pancreatic Cancer Immuno-oncology in the Era of Precision Medicine
    Hegde, Samarth
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2021, 12 (SUPPL 1) : 118 - 127
  • [3] Pancreatic Cancer Immuno-oncology in the Era of Precision Medicine
    Samarth Hegde
    Indian Journal of Surgical Oncology, 2021, 12 : 118 - 127
  • [4] Precision Medicine in Oncology II: Economics of Targeted Agents and Immuno-Oncology Drugs
    Huntington, Scott F.
    Davidoff, Amy J.
    Gross, Cary P.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04) : 351 - +
  • [5] Longitudinal ctDNA profiling in precision oncology and immuno-oncology
    Filis, Panagiotis
    Kyrochristos, Ioannis
    Korakaki, Efterpi
    Baltagiannis, Evangelos G.
    Thanos, Dimitris
    Roukos, Dimitrios H.
    DRUG DISCOVERY TODAY, 2023, 28 (04) : 1 - 15
  • [6] Organoids as an Enabler of Precision Immuno-Oncology
    Zhao, Junzhe
    Fong, Antoinette
    Seow, See Voon
    Toh, Han Chong
    CELLS, 2023, 12 (08)
  • [7] Immuno-Oncology in the Era of Personalized Medicine
    Gwin, William R., III
    Disis, Mary L.
    Ruiz-Garcia, Erika
    TRANSLATIONAL RESEARCH AND ONCO-OMICS APPLICATIONS IN THE ERA OF CANCER PERSONAL GENOMICS, 2019, 1168 : 117 - 129
  • [8] Immuno-oncology
    Gallimore, Awen
    Tournier, Cathy
    ESSAYS IN BIOCHEMISTRY, 2023, 67 (06) : 903 - 903
  • [9] Epistemic dwelling: precision immuno-oncology by design
    Chiapperino, Luca
    Graber, Nils
    Panese, Francesco
    NEW GENETICS AND SOCIETY, 2021, 40 (01) : 26 - 41
  • [10] Improving Precision and Implementation of Immuno-Oncology Biomarkers
    Suteja, Lisda
    Yeong, Joe
    Tan, Aaron C.
    Toy, Weiyi
    Tan, Daniel S. W.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : E91 - E93